Pneumococcal Disease Prevention in Allogeneic Hematopoietic Stem Cell Transplant Recipients
📧 Sign up to get email alerts when something new happens for Pneumococcal Disease Prevention in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients [Phase 3]
A Phase 3 trial evaluating sequential vaccination with 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysacch…